Literature DB >> 22771083

Inflammation and apoptosis in hypertension. Relevance of the extent of target organ damage.

Pedro Morillas1, Helder de Andrade, Jesus Castillo, Juan Quiles, Vicente Bertomeu-González, Alberto Cordero, Estefanía Tarazón, Esther Roselló, Manuel Portolés, Miguel Rivera, Vicente Bertomeu-Martínez.   

Abstract

INTRODUCTION AND
OBJECTIVES: To investigate the relationship between inflammatory and apoptotic parameters and the severity and extent of target organ damage in patients with essential hypertension.
METHODS: We studied 159 consecutive patients with treated essential hypertension. An exhaustive evaluation of damage to heart, kidney, and blood vessels was performed and plasma levels of inflammatory (interleukin 6 and soluble receptor of tumor necrosis factor-alpha type 2) and apoptotic markers (soluble receptor of tumor necrosis factor-alpha type 1 and soluble Fas receptor) were determined. Patients were categorized into four groups: a) no organ damage (33 patients); b) 1 organ damaged (52 patients); c) 2 organs damaged (44 patients), and d) 3 organs damaged (30 patients).
RESULTS: Serum levels of interleukin 6, soluble receptor of tumor necrosis factor-alpha type 1 and soluble receptor of tumor necrosis factor-alpha type 2 were higher in patients with target organ damage than in hypertensive patients without organ damage. Increasing levels of these molecules were progressively associated with an increase in the number of organs damaged, and the highest levels were observed in the group with damage to 3 organs (heart, kidney, and blood vessels). There were no differences in soluble Fas receptor levels between groups. Logistic regression analysis showed that age, smoking, diabetes mellitus, abdominal circumference, interleukin 6, and soluble receptor of tumor necrosis factor-alpha type 1 were independently related to the number of target organs damaged.
CONCLUSIONS: Extensive hypertensive disease with involvement of more target organs was associated with greater inflammatory and apoptotic activation in these hypertensive patients.
Copyright © 2012 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771083     DOI: 10.1016/j.recesp.2012.03.020

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  10 in total

1.  Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns.

Authors:  Soo Jeong Park; Jeong Mi Kim; Jihyo Kim; Jaehark Hur; Sun Park; Kyongmin Kim; Ho-Joon Shin; Yong-Joon Chwae
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-21       Impact factor: 11.205

2.  Correlative association of interleukin-6 with intima media thickness: a meta-analysis.

Authors:  Bo Zhang; Jing Wang; Yong Xu; Xiao Zhou; Junsong Liu; Jing Xu; Bo Li; Guang Zhi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Racial Disparity in Cognitive and Functional Disability in Hypertension and All-Cause Mortality.

Authors:  Ihab Hajjar; Whitney Wharton; Wendy J Mack; Allan I Levey; Felicia C Goldstein
Journal:  Am J Hypertens       Date:  2015-07-01       Impact factor: 2.689

4.  The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients.

Authors:  Ihsan Ates; Nihal Ozkayar; Fatma Akyel; Canan Topcuoglu; Serdar Akyel; A Nurdan Barça; Fatih Dede
Journal:  BMC Nephrol       Date:  2014-10-01       Impact factor: 2.388

5.  The concentration of tumor necrosis factor in the blood serum and in the urine and selected early organ damages in patients with primary systemic arterial hypertension.

Authors:  Anna Puszkarska; Arkadiusz Niklas; Jerzy Głuszek; Dawid Lipski; Karolina Niklas
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

6.  Blood pressure-related differences in brain health between young African Americans and Caucasian Americans.

Authors:  Junyeon Won; Sushant M Ranadive; Daniel D Callow; Shuo Chen; J Carson Smith
Journal:  Physiol Rep       Date:  2021-03

7.  Potential mechanisms of Guizhi decoction against hypertension based on network pharmacology and Dahl salt-sensitive rat model.

Authors:  Jiye Chen; Yongjian Zhang; Yongcheng Wang; Ping Jiang; Guofeng Zhou; Zhaoyu Li; Jinlong Yang; Xiao Li
Journal:  Chin Med       Date:  2021-04-27       Impact factor: 5.455

8.  Influence of Hypersensitive C-Reactive Protein on the Effect of Continuous Antihypertensive Pharmacological Therapy.

Authors:  Minghui Bao; Yongjian Song; Shouling Wu; Jianping Li
Journal:  J Cardiovasc Pharmacol       Date:  2022-07-01       Impact factor: 3.271

9.  Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach.

Authors:  Shengjun Fan; Qiang Geng; Zhenyu Pan; Xin Li; Lu Tie; Yan Pan; Xuejun Li
Journal:  BMC Syst Biol       Date:  2012-12-10

10.  The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension.

Authors:  Michał Biernacki; Wojciech Łuczaj; Iwona Jarocka-Karpowicz; Ewa Ambrożewicz; Marek Toczek; Elżbieta Skrzydlewska
Journal:  Molecules       Date:  2018-09-14       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.